
Abstract Aim Managing infected wounds and controlling oxidative stress, inflammation, and microbial infections during the wound-healing process present significant challenges in both human and veterinary medicine. This study aimed to develop a herbal cream based on Linaria scariosa (LS) extract and evaluate its wound healing, antioxidant, antimicrobial, and anti-inflammatory effects. Material and Methods The LS-herbal cream was formulated using a water/oil emulsion, following standard procedures, and its physicochemical, rheological, and microbiological properties were verified. The in vivo wound-healing effect was evaluated using the excision wound model. The in vitro anti-inflammatory activity was assessed by the heat-induced hemolysis method, while antioxidant activity was evaluated through five different assays. Moreover, antimicrobial activity was tested using the disk agar diffusion method. Results Moderate to low contents of terpenoids, flavonoids, phenolics, and carotenoids were estimated. The LS-cream exhibited a significant ability to inhibit thermally induced hemolysis (IC 50 = 338.01±0.25 μg/mL). Moreover, it showed moderate antimicrobial effects against all the tested strains. LS-cream displayed moderate total antioxidant capacity, DPPH radical scavenging, permanganate-reducing, and iron chelating effects. The formulation showed good stability, a skin-compatible pH (6.8 ± 0.09), a satisfactory microbiological safety profile, and acceptable physicochemical and rheological properties after storage. Topical application of the LS-cream on excision wounds resulted in a significant wound-healing effect, including increased wound contraction rates and a reduced epithelization period (16.33±0.22 days). Histopathological examination indicated that the observed enhancement in healing was mainly due to improved epithelialization and favorable histological features consistent with tissue remodeling and repair. Conclusion The LS-herbal cream demonstrates a promising pharmaceutical formulation with effective wound-healing, anti-inflammatory, antimicrobial, and antioxidant properties.
Abstract This study aimed to evaluate the influence of glutathione-based systems—poly(acrylic acid)-glutathione (PAA-GSH), chitosan-glutathione (ch.GSH), and free glutathione (GSH)—on the intestinal permeability of vingerbine alkaloids. The transepithelial transport of herbamine, herbadine, and vincarine was investigated using the Caco-2 cell monolayer model. Apical-to-basolateral and basolateral-to-apical fluxes were measured in the presence of PAA-GSH, ch.GSH, or free GSH to assess their effects on absorptive permeability and efflux-related processes. PAA-GSH significantly enhanced apical-to-basolateral transport, increasing permeability by 3.4-, 2.59-, and 1.52-fold for herbamine, herbadine, and vincarine, respectively, consistent with thiol-mediated reversible modulation of epithelial tight junctions. In contrast, ch.GSH reduced absorptive transport (1.28-, 1.67-, and 1.51-fold) and markedly decreased basolateral efflux, suggesting polymer–drug complex formation and reduced availability of free drug. Free GSH showed minimal influence on alkaloid permeability. These findings demonstrate that polymer architecture critically determines the intestinal transport behavior of vingerbine alkaloids. PAA-GSH acts as an effective permeation enhancer and represents a promising carrier for improving the intestinal delivery of tested compounds. Future studies will focus on developing optimized delivery systems for this anti-arrhythmic agent.
Abstract Aim Using natural ingredients in cosmetics, such as sunscreen, offers a promising approach to creating more environmentally sustainable products. This study aimed to evaluate the feasibility of formulating a sunscreen body lotion containing tangerine oil by assessing its quality, stability, SPF value, and consumer acceptance. Materials and Methods The study involved phytochemical screening and chemical compound identification using gas chromatography-mass spectrometry (GC-MS). Antioxidant activity was measured using the DPPH method. Additional tests included organoleptic evaluation, homogeneity, pH, viscosity, spreadability, adhesion, emulsion type, particle size, functional group identification, SPF determination, accelerated stability testing (heating–cooling cycles), and hedonic testing. Results D-limonene was identified as the dominant compound in tangerine oil. It showed weak antioxidant activity, with an IC 50 value of 72,015.29 ppm and an antioxidant activity index (AAI) of 0.007. All five formulations met the required quality standards. The highest SPF value (13.59) was achieved by the formulation containing 3% TiO 2 and 9% tangerine oil, measured in vitro using a UV–Vis spectrophotometer. Stability testing over six heating–cooling cycles confirmed that all formulations remained stable. In hedonic testing, formula F4 (3% TiO 2 and 12% tangerine oil) was the most preferred by panelists. Conclusions Although tangerine oil exhibited negligible antioxidant activity, the study successfully developed stable body lotion formulations that met quality requirements, provided maximum sun protection, and were well accepted by users.
The present study aimed to develop and optimize posaconazole-conjugated graphene (PCZ-G) microgel for the treatment of cutaneous infections caused by fungus Aspergillus niger (A. niger). The Box–Behnken experimental design with three levels, three factors, and three center points was applied for optimization of PCZ-G microgel. Particle size (PS), polydispersity index (PDI), and entrapment efficiency were the three outputs utilized in the design matrix associated with Box–Behnken design (BBD), containing 17 runs. Three-dimensional response surface plots and contour plots have been generated using Stat Ease 360 software. On the optimized preparation, assessments were conducted on drug content, %CDR, PDI, PS, percentage entrapment efficiency (EE%), and in vitro antifungal activity. The optimized formulation of PCZ-G microgel showed a particle size of 1506 nm, an entrapment efficiency of 97.08±3.69%, a drug content of 94.43±1.09%, and other parameters all within the range of the model. In vitro release study showed prolonged drug release from the optimized formulation. Drugs and excipients were well integrated and physically stable in the designed microgel, which showed significant antifungal activity against A. niger.